Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk.
Naik S, Pal D, Shukla S, Kumar V, Kumar A, Jha V, Minz R, Sethi J, Bharati J, Divyaveer S, Kumar V, Rathi M, Kohli HS, Ramachandran R.
Naik S, et al. Among authors: bharati j.
Kidney Int Rep. 2023 May 16;8(8):1660-1664. doi: 10.1016/j.ekir.2023.05.009. eCollection 2023 Aug.
Kidney Int Rep. 2023.
PMID: 37547518
Free PMC article.
No abstract available.